Epigenetic modulation of immunotherapy and implications in head and neck cancer
Epigenetic modulation of immunotherapy and implications in head and neck cancer
About this item
Full title
Author / Creator
Publisher
New York: Springer US
Journal title
Language
English
Formats
Publication information
Publisher
New York: Springer US
Subjects
More information
Scope and Contents
Contents
Cancer progression is facilitated by distinct mechanisms developed by cancer cells to avoid immune recognition and clearance. The clinical application of immune checkpoint blockade (ICB),
via
monoclonal antibodies blocking PD-1/PD-L1 and CTLA4, has achieved promising durable therapeutic response in various cancer types, including recurrent an...
Alternative Titles
Full title
Epigenetic modulation of immunotherapy and implications in head and neck cancer
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7897200
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7897200
Other Identifiers
ISSN
0167-7659
E-ISSN
1573-7233
DOI
10.1007/s10555-020-09944-0
